Esculentoside C

CAS No. 65931-92-2

Esculentoside C( —— )

Catalog No. M30913 CAS No. 65931-92-2

Esculentoside C exerts proinflammatory effects synergistically, it can induce inflammatory stimulation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 567 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Esculentoside C
  • Note
    Research use only, not for human use.
  • Brief Description
    Esculentoside C exerts proinflammatory effects synergistically, it can induce inflammatory stimulation.
  • Description
    Esculentoside C exerts proinflammatory effects synergistically, it can induce inflammatory stimulation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    65931-92-2
  • Formula Weight
    810.97
  • Molecular Formula
    C42H66O15
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • SARS-CoV-2 Mpro-IN-9

    SARS-CoV-2 Mpro-IN-9 (compound c7), a nonpeptidic, noncovalent inhibitor of SARS-CoV-2 main protease (Mpro), exhibits potent inhibitory action (IC50 = 0.085 μM) and improved physicochemical and drug metabolism and pharmacokinetics (DMPK) properties.

  • SBI993

    SBI993 is an analog of SBI-477 and can be used as a biomarker to confirm the expected action of MondoA target gene expression in vivo. SBI993 reduces muscle TAG levels and hepatic steatosis.

  • Emorfazone

    Emorfazone has an anti-nociceptive effect.